全人重链可变区和修饰后恒定区

与RenMab可比的强健的免疫反应

RenNano来源的抗原特异性抗体多样性好

纳摩级别的高亲和力

良好的成药性

资料下载

AACR 2023: RenNano^® Mice: A Heavy-Chain-Only Antibody Platform for the Generation of Nanobody Therapeutics

AACR 2023: Discovery of RenNano®-Derived Human Heavy-Chain-Only Antibodies That Cross the Blood-Brain-Barrier

网络研讨会

2024年1月24日 | Maximize Your Drug Design Possibilities with RenNano-derived Fully Human Nanobodies